Abstract:
Provided is a display apparatus including: a display; a content interface; a communication interface; and a controller configured to: control the display to display an image corresponding to the broadcast signal received through the content interface; receive operation information of an external audio apparatus through at least one interface selected from the content interface and the communication interface; and control the display to display a control menu for providing the operation information of the external audio apparatus and acquiring a user input related to an operation of the external audio apparatus in response to the operation information of the external audio apparatus being received.
Abstract:
A display device is disclosed. According to the present invention, a display device comprises: a sensor; a display; a storage unit in which history information on content provided by the display device is stored; and a processor for acquiring, through the sensor, information on the distance between a user and the display device if a preset event occurs, displaying a background screen in the display if the user is identified, on the basis of the acquired information, as existing in a first region among a plurality of regions classified according to the distance from the display device, providing content on the basis of first history information if the user is identified, on the basis of the acquired information, as existing in a second region among the plurality of regions, and providing content on the basis of second history information if the user is identified, on the basis of the acquired information, as existing in a third region among the plurality of regions, wherein the first history information can include information on content provided by the display device during the existence of the user in the second region, and the second history information can include information on content provided by the display device during the existence of the user in the third region. The display device can provide content by using an artificial intelligence (AI) model having been taught according to at least one of machine learning, neural network and deep learning algorithms, in the providing the content.
Abstract:
A method of predicting an effect of a c-Met inhibitor and/or selecting a subject for application of a c-Met inhibitor using TFF1, a method of monitoring an effect of a c-Met inhibitor using TFF1, and a method of treating and/or preventing cancer including administering a c-Met inhibitor to the selected subject.
Abstract:
A method of predicting an effect of an anti-c-Met antibody and/or selecting a subject for application of an anti-c-Met antibody including measuring a level of the biomarker in a biological sample, is provided.
Abstract:
A method of predicting an effect of an anti-c-Met antibody and/or selecting a subject for application of an anti-c-Met antibody including measuring a level of the biomarker in a biological sample, is provided.
Abstract:
A method and apparatus for analyzing genetic data of a subject generates a plurality of bootstrap data sets having binary response variables related to a specific response from the genetic data; determines a first bootstrap data set that represents the bootstrap data sets, based on distributions of the binary response variables; generates permutation null distributions by permutating the first bootstrap data set P (where P is a natural number) times; and calculates an empirical power of the bootstrap data sets by testing respective levels of significance of the bootstrap data sets based on the permutation null distributions.
Abstract:
A method and apparatus for diagnosing cancer by using genetic information, the method comprising acquiring first gene expression data of a subject, for whom cancer is to be diagnosed, for a gene marker set including at least one gene marker; and determining a possibility of a presence of the cancer of the subject by using the acquired first gene expression data and pre-stored second gene expression data of a normal person group and a cancer patient group, wherein the gene marker set includes gene markers such as pyrroline-5-carboxylate reductase 1 (PYCR1), phosphoglycerate dehydrogenase (PHGDH), glutaminase 2 (liver, mitochondrial) (GLS2), and glutaminase (GLS) among others.
Abstract:
FIG. 1 is a front view of the first image in a sequence for a display screen or portion thereof with transitional graphical user interface showing our new design according to a first embodiment; FIG. 2 is the second image thereof; FIG. 3 is another front view of the first image thereof, showing only the claimed features, separately for clarity of illustration; FIG. 4 is another front view of the second image thereof, showing only the claimed features, separately for clarity of illustration; FIG. 5 is a front view of the first image in a sequence for a display screen or portion thereof with transitional graphical user interface showing our new design according to a second embodiment; FIG. 6 is the second image thereof; FIG. 7 is another front view of the first image thereof, showing only the claimed features, separately for clarity of illustration; and, FIG. 8 is another front view of the second image thereof, showing only the claimed features, separately for clarity of illustration. The thicker dashed lines shown in FIGS. 2, 4, 6, and 8 form part of the claimed design. The outer perimeter shown in broken lines in the figures illustrates a display screen or portion thereof and forms no part of the claimed design. The remaining broken lines in the figures illustrate portions of the graphical user interface that form no part of the claimed design. The appearance of the transitional image sequentially transitions between the images shown in FIGS. 1-2 and 5-6, respectively. The process or period in which one image transitions to another image forms no part of the claimed design.
Abstract:
A method of predicting an effect of a c-Met inhibitor and/or selecting a subject for application of a c-Met inhibitor using TFF1, a method of monitoring an effect of a c-Met inhibitor using TFF1, and a method of treating and/or preventing cancer including administering a c-Met inhibitor to the selected subject.